{"id":1483,"date":"2019-05-30T23:19:14","date_gmt":"2019-05-31T03:19:14","guid":{"rendered":"https:\/\/www.nikola.jp\/needs\/?post_type=job_listing&#038;p=1483"},"modified":"2019-07-01T04:32:28","modified_gmt":"2019-07-01T08:32:28","slug":"1209-%e6%8a%80%e8%a1%93%e5%8b%9f%e9%9b%86%ef%bc%9avaccines","status":"publish","type":"job_listing","link":"https:\/\/www.nikola.jp\/needs\/job\/1209-%e6%8a%80%e8%a1%93%e5%8b%9f%e9%9b%86%ef%bc%9avaccines\/","title":{"rendered":"1209 \u6280\u8853\u52df\u96c6\uff1aVaccines"},"content":{"rendered":"<p>Pfizer\u304cVaccines\u306b\u95a2\u3059\u308b\u6280\u8853\u3092\u52df\u96c6\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>Our vision is to become a recognized leader in the discovery and development of innovative prophylactic and therapeutic vaccines for unmet medical needs throughout all stages of life and for all geographies and markets. We focus on Prevention of viral and bacterial infections in infants, children, adolescents and older adults; hospital acquired infections; and active immune oncology (cancer vaccine) targets,<\/p>\n<p>We are interested in establishing alliances to develop and access:<\/p>\n<p>-Vaccines for the prevention and\/or treatment of infectious diseases<\/p>\n<p>-Vaccines for the prevention and\/or treatment of non-infectious diseases with special emphasis on cancer vaccines through the active elicitation of disease-modifying immune responses<\/p>\n<p>Specific areas of interest include:<\/p>\n<p>-Adjuvants<\/p>\n<p>-Novel immune system enhancers to bolster the immune system of an older population<\/p>\n<p>-Novel in vitro systems for assessment of vaccine immunogenicity<\/p>\n<p>-Novel animal models for assessment of vaccine effectiveness<\/p>\n<p>-Novel immunomodulators of the adaptive immune response<\/p>\n<p>-Novel vaccine target antigen identification systems<\/p>\n<p>-Novel vaccine delivery platforms<\/p>\n<p>-Novel vaccine platforms with game-changing potential<\/p>\n<p>\u203b\u4ee5\u4e0a\u306e\u6280\u8853\u30cb\u30fc\u30ba\u60c5\u5831\u306f\u3001\u30cb\u30fc\u30ba\u63d0\u4f9b\u8005\u304c\u516c\u5f0f\u30a6\u30a7\u30d6\u30b5\u30a4\u30c8\u3084\u5c55\u793a\u4f1a\u306a\u3069\u306b\u516c\u958b\u3057\u3066\u3044\u308b\u3082\u306eJTG\u306b\u3066\u53d6\u5f97\u3057\u7de8\u96c6\u3057\u305f\u3082\u306e\u3067\u3059\u3002<\/p>\n","protected":false},"author":18,"featured_media":1333,"template":"","meta":{"_company_name":"Pfizer","_job_location":"","_application":"skimura@keisenassociates.com","_company_tagline":"Pfizer\u304cVaccines\u306b\u95a2\u3059\u308b\u6280\u8853\u3092\u52df\u96c6\u3057\u3066\u3044\u307e\u3059\u3002","_company_video":"","_company_website":"https:\/\/www.pfizer.com\/partners\/highlights","_company_twitter":"","_filled":0,"_featured":0,"_remote_position":0,"_job_salary":"","_job_salary_currency":"","_job_salary_unit":""},"job_listing_region":[],"job-categories":[65,68,69,70],"job-types":[52,53],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.nikola.jp\/needs\/wp-json\/wp\/v2\/job-listings\/1483"}],"collection":[{"href":"https:\/\/www.nikola.jp\/needs\/wp-json\/wp\/v2\/job-listings"}],"about":[{"href":"https:\/\/www.nikola.jp\/needs\/wp-json\/wp\/v2\/types\/job_listing"}],"author":[{"embeddable":true,"href":"https:\/\/www.nikola.jp\/needs\/wp-json\/wp\/v2\/users\/18"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nikola.jp\/needs\/wp-json\/wp\/v2\/media\/1333"}],"wp:attachment":[{"href":"https:\/\/www.nikola.jp\/needs\/wp-json\/wp\/v2\/media?parent=1483"}],"wp:term":[{"taxonomy":"job_listing_region","embeddable":true,"href":"https:\/\/www.nikola.jp\/needs\/wp-json\/wp\/v2\/job_listing_region?post=1483"},{"taxonomy":"job_listing_category","embeddable":true,"href":"https:\/\/www.nikola.jp\/needs\/wp-json\/wp\/v2\/job-categories?post=1483"},{"taxonomy":"job_listing_type","embeddable":true,"href":"https:\/\/www.nikola.jp\/needs\/wp-json\/wp\/v2\/job-types?post=1483"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}